Clover Health Investments Operating Income 2020-2023 | CLOV
Clover Health Investments Annual Operating Income (Millions of US $) |
|
---|---|
2023 | $-209 |
2022 | $-372 |
2021 | $-637 |
2020 | $-93 |
2019 | $-183 |
Clover Health Investments Quarterly Operating Income (Millions of US $) |
|
---|---|
2023-12-31 | $-66 |
2023-09-30 | $-41 |
2023-06-30 | $-29 |
2023-03-31 | $-73 |
2022-12-31 | $-107 |
2022-09-30 | $-74 |
2022-06-30 | $-103 |
2022-03-31 | $-87 |
2021-12-31 | $-187 |
2021-09-30 | $-149 |
2021-06-30 | $-182 |
2021-03-31 | $-119 |
2020-12-31 | $-68 |
2020-09-30 | $-22 |
2020-06-30 | $23 |
2020-03-31 | $-27 |
2019-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.318B | $2.034B |
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $35.723B | 19.61 |
Inspire Medical Systems (INSP) | United States | $7.393B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.477B | 0.00 |
Axonics (AXNX) | United States | $3.412B | 0.00 |
10x Genomics (TXG) | United States | $3.208B | 0.00 |
Enovis (ENOV) | United States | $3.038B | 23.08 |
Azenta (AZTA) | United States | $2.905B | 236.82 |
Olink Holding AB (publ) (OLK) | Sweden | $2.820B | 0.00 |
Hims & Hers Health (HIMS) | United States | $2.680B | 0.00 |
Privia Health (PRVA) | United States | $2.139B | 94.89 |
Schrodinger (SDGR) | United States | $1.827B | 0.00 |
Omnicell (OMCL) | United States | $1.248B | 30.53 |
Phreesia (PHR) | United States | $1.185B | 0.00 |
Definitive Healthcare (DH) | United States | $0.821B | 0.00 |
Standard BioTools (LAB) | United States | $0.737B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.680B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.619B | 0.00 |
Talkspace (TALK) | United States | $0.536B | 0.00 |
Health Catalyst (HCAT) | United States | $0.373B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.329B | 0.00 |
Pulmonx (LUNG) | United States | $0.298B | 0.00 |
P3 Health Partners (PIII) | United States | $0.183B | 0.00 |
Butterfly Network (BFLY) | United States | $0.164B | 0.00 |
American Well (AMWL) | United States | $0.154B | 0.00 |
Outset Medical (OM) | United States | $0.147B | 0.00 |
MSP Recovery (LIFW) | United States | $0.129B | 0.00 |
Augmedix (AUGX) | United States | $0.124B | 0.00 |
TruBridge (TBRG) | United States | $0.118B | 5.04 |
111 (YI) | China | $0.088B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
HeartBeam (BEAT) | United States | $0.057B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
Movano (MOVE) | United States | $0.048B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
Akili (AKLI) | United States | $0.031B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
Cue Health (HLTH) | United States | $0.021B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
CareCloud (CCLD) | United States | $0.018B | 0.00 |
ETAO (ETAO) | United States | $0.016B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.013B | 0.00 |
Transgenomic (PRPO) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Syra Health (SYRA) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |